Avalo Therapeutics | 8-K: Current report
Mar 29 16:08 ET
Avalo Therapeutics | DEFA14A: Others
Mar 28 06:29 ET
Avalo Therapeutics | 8-K: Current report
Mar 28 06:14 ET
Avalo Therapeutics | 8-K: Current report
Jan 31 16:03 ET
Avalo Therapeutics | 8-K: Current report
Dec 28, 2023 00:00 ET
Avalo Therapeutics | 8-K: Current report
Dec 20, 2023 16:01 ET
Avalo Therapeutics | DEFA14A: Others
Dec 7, 2023 07:02 ET
Avalo Therapeutics | 8-K: Current report
Dec 7, 2023 07:01 ET
Avalo Therapeutics | 8-K: Current report
Nov 16, 2023 07:15 ET
Avalo Therapeutics | 8-K: Avalo Reports Third Quarter 2023 Financial Results and Provides Business Updates
Nov 9, 2023 07:04 ET
Avalo Therapeutics | 8-K: Current report
Oct 31, 2023 07:21 ET
Avalo Therapeutics | DEFA14A: Others
Oct 19, 2023 16:06 ET
Avalo Therapeutics | DEF 14A: Definitive information statements
Oct 19, 2023 16:01 ET
Avalo Therapeutics | 8-K: Current report
Oct 17, 2023 16:02 ET
Avalo Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Oct 5, 2023 16:02 ET
Avalo Therapeutics | 8-K: Current report
Oct 3, 2023 16:05 ET
Avalo Therapeutics | 8-K: Current report
Sep 26, 2023 07:04 ET
Avalo Therapeutics | 8-K: Current report
Sep 13, 2023 16:03 ET
Avalo Therapeutics | 8-K: Current report
Sep 13, 2023 09:12 ET
Avalo Therapeutics | 8-K: Current report
Sep 12, 2023 07:10 ET
No Data
No Data